Provectus Biopharmaceuticals, Inc. (OTC: PVCT) - For an in-depth report on Provectus Biopharmaceuticals, Inc. follow: www.BullTrends.com/stockquote/PVCT
Shares of Provectus Biopharmaceuticals closed up 25.33% on about 3 million shares traded. The stock was one of the biggest gainers in the OTC market. The company announced that data on its investigational agent PV-10 for intralesional (IL) treatment of locally advanced cutaneous melanoma will be featured in two presentations in the Poster Highlights Session, Melanoma/Skin Cancers, on June 2, 2014 during the American Society of Clinical Oncology (ASCO) annual meeting to be held at McCormick Place, Chicago, IL.
Summer Infant, Inc. (NASDAQ: SUMR) - For an in-depth report on Summer Infant, Inc. follow: www.BullTrends.com/stockquote/SUMR
Shares of Summer Infant Inc. closed up 51.81% on about 4.6 million shares traded. The stock was one of the biggest gainers on the NASDAQ. The company beat analysts’ estimates for earnings and revenue in the first quarter. For Q1, the company posted earnings of 5 cents a share, beating the Capital IQ Consensus Estimate of a loss of -1 cent a share by 6 cents. The company posted revenue of $50.81 million for the quarter. Analysts had expected revenue of $45.22 million.
Sears Holdings Corporation (NASDAQ: SHLD) - For an in-depth report on Sears Holdings Corporation follow: www.BullTrends.com/stockquote/SHLD
Sears Holdings Corporation closed down 5.85% on nearly 2.5 million shares traded. The stock was one of the biggest decliners on the NASDAQ. The company is considering selling its Canadian operations. Sears Holding is looking at strategic options for its 51 percent interest in Sears Canada.
Macy's, Inc. (NYSE: M) - For an in-depth report on Macy's, Inc. follow: www.BullTrends.com/stockquote/M
Shares of Macy’s Inc. barely closed in the red on Wednesday with about 11.5 million shares traded. The company reported that first quarter net income rose 3% from a year ago as the company lowered its cost of sales. Macy’s net income totaled $224 million, up from $217 million a year ago. Earnings per share came in at 60 cents and beat analysts' estimates of 59 cents.
Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.